Nuveen’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-371,403
Closed -$25.2M 3306
2019
Q3
$25.2M Sell
371,403
-63,359
-15% -$4.35M 0.01% 1008
2019
Q2
$25.3M Buy
+434,762
New +$25.8M 0.01% 1034

Nuveen's GHDX Position: Q4 2019 in Review

Nuveen sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 371,403 shares — an estimated $25.2M sold.

Nuveen first reported a position in GHDX in Q2 2019 and held it in 2 quarters. The position peaked at $25.3M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Nuveen reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Nuveen sold 371,403 Genomic Health, Inc. shares in Q4 2019, an estimated $25.2M.
  • Nuveen first reported a position in Genomic Health, Inc. in Q2 2019 and held it in 2 quarters.
  • Nuveen's Genomic Health, Inc. position peaked at $25.3M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.